Compounds > azimexon
Page last updated: 2024-08-23

azimexon and Lung Neoplasms

azimexon has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goutner, A; Huchet, R; Mathé, G; Thomas, Y1
Bicker, U; Maus, W; Probst, E1
Chirigos, MA; Lauer, L; Papademetriou, V; Stylos, WA1

Other Studies

3 other study(ies) available for azimexon and Lung Neoplasms

ArticleYear
[Immune monitoring of the cancer patient: suppressor cells and NK cells].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1980, Volume: 174, Issue:4

    Topics: Adjuvants, Immunologic; Aziridines; Cytotoxicity, Immunologic; Drug Hypersensitivity; Hodgkin Disease; Humans; Hypersensitivity, Delayed; Interferons; Killer Cells, Natural; Lung Neoplasms; Lymphokines; T-Lymphocytes, Regulatory

1980
Influence of the immunostimulating compound azimexone (2-[2-Cyanaziridinyl-(1)]-2-[2-carbamoylaziridinyl-(1)]-propane) on the number of metastases in the Lewis lung carcinoma in mice.
    Experimental pathology, 1981, Volume: 19, Issue:1

    Topics: Animals; Aziridines; Azirines; Lung Neoplasms; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Isogeneic

1981
The immunomodulatory effect on BM 12.531 (azimexon) on normal or tumored mice: in vitro and in vivo studies.
    Journal of immunopharmacology, 1980, Volume: 2, Issue:1

    Topics: Animals; Ascitic Fluid; Aziridines; Azirines; Cells, Cultured; Hypersensitivity, Delayed; Immunity, Cellular; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; X-Rays

1980